ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,781Medicare Part D Prescriptions Filled, Including Refills

Rank: 208 out of 1448

$420K Total Retail Price of All Prescriptions

Rank: 186 out of 1448

469 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

7% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 5,068 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL TARTRATE 370 351 1 9
SIMVASTATIN 360 321 2 3
LISINOPRIL 261 229 3 5
LOSARTAN POTASSIUM 190 179 4 11
AMLODIPINE BESYLATE 176 160 5 2
METOPROLOL SUCCINATE 137 105 6 6
NIFEDIPINE ER 134 124 7 59
WARFARIN SODIUM 128 117 8 8
OMEPRAZOLE 119 99 9 23
FUROSEMIDE 114 100 10 7
FAMOTIDINE 111 101 11 60
ZOLPIDEM TARTRATE 110 99 12 34
METFORMIN HCL 110 85 12 25
LEVOTHYROXINE SODIUM 106 102 14 21
HYDROCODONE-ACETAMINOPHEN 101 86 S3 15 33
DIGOXIN 96 89 16 13
GLIPIZIDE 88 73 17 75
ALENDRONATE SODIUM 88 88 17 41
CARVEDILOL 83 75 19 1
GABAPENTIN 70 42 20 51
ATENOLOL 67 60 21 12
ISOSORBIDE MONONITRATE ER 63 63 22 16
HYDROCHLOROTHIAZIDE 62 55 23 18
CLONIDINE HCL 61 42 24 45
TAMSULOSIN HCL 61 55 24 46
NIFEDICAL XL 57 56 26 162
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.